VIX
41
-11
AMAT
33
3
USB
50
3
ACN
54
2
XRX
48
2
DOW
47
4
NRG
32
5
KMI
69
8
COP
36
2
CF
47
5
DRI
74
5
CMA
42
3
ECL
54
5
FITB
36
3
LEG
16
2
NWSA
69
4
HCP
54
2
SBUX
29
-2
NDAQ
46
2
EQT
47
13
VIX
41
-11
AMAT
33
3
USB
50
3
ACN
54
2
XRX
48
2
DOW
47
4
NRG
32
5
KMI
69
8
COP
36
2
CF
47
5
DRI
74
5
CMA
42
3
ECL
54
5
FITB
36
3
LEG
16
2
NWSA
69
4
HCP
54
2
SBUX
29
-2
NDAQ
46
2
EQT
47
13
Financhill
Back

Akero Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
32

AKRO
Akero Therapeutics

Last Price:
$29.35
Seasonality Move:
-9.11%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
32
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $29.34. The Score for AKRO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $29.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 45.72 Sell
Chaikin Money Flow: 761403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.2 - 31.7) Sell
Bollinger Bands (100): (26.09 - 31.31) Buy

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.33 Buy
20-day SMA: 30.54 Sell
50-day SMA: 30.81 Sell
200-day SMA: 25.92 Buy
8-day EMA: 29.44 Sell
20-day EMA: 30.1 Sell
50-day EMA: 30.09 Sell
200-day EMA: 27.83 Buy

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):